ArticleClinical and experimental nephrology2018

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy.

Hitoshi Sakuraba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.